149 related articles for article (PubMed ID: 24882038)
1. Oral sustained-release suspension based on a novel taste-masked and mucoadhesive carrier-ion-exchange fiber.
Yuan J; Liu T; Li H; Shi T; Xu J; Liu H; Wang Z; Wang Q; Xu L; Wang Y; Li S
Int J Pharm; 2014 Sep; 472(1-2):74-81. PubMed ID: 24882038
[TBL] [Abstract][Full Text] [Related]
2. Nanosponge-based pediatric-controlled release dry suspension of Gabapentin for reconstitution.
Rao MR; Bhingole RC
Drug Dev Ind Pharm; 2015; 41(12):2029-36. PubMed ID: 26006328
[TBL] [Abstract][Full Text] [Related]
3. Exploring the potential of self-assembled mixed micelles in enhancing the stability and oral bioavailability of an acid-labile drug.
Zhang X; Wang H; Zhang T; Zhou X; Wu B
Eur J Pharm Sci; 2014 Oct; 62():301-8. PubMed ID: 24956461
[TBL] [Abstract][Full Text] [Related]
4. Sustained ophthalmic delivery of highly soluble drug using pH-triggered inner layer-embedded contact lens.
Zhu Q; Cheng H; Huo Y; Mao S
Int J Pharm; 2018 Jun; 544(1):100-111. PubMed ID: 29627356
[TBL] [Abstract][Full Text] [Related]
5. Core-shell structured gel-nanocarriers for sustained drug release and enhanced antitumor effect.
He W; Lv Y; Zhao Y; Xu C; Jin Z; Qin C; Yin L
Int J Pharm; 2015 Apr; 484(1-2):163-71. PubMed ID: 25724136
[TBL] [Abstract][Full Text] [Related]
6. Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading.
Li P; Tan A; Prestidge CA; Nielsen HM; Müllertz A
Int J Pharm; 2014 Dec; 477(1-2):390-8. PubMed ID: 25455781
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
Hu LD; Liu Y; Tang X; Zhang Q
Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
[TBL] [Abstract][Full Text] [Related]
8. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability.
He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L
Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310
[TBL] [Abstract][Full Text] [Related]
9. Formulation and development of oral dry suspension using taste masked Ornidazole particles prepared using Kollicoat(®) Smartseal 30 D.
Chivate A; Sargar V; Nalawade P; Tawde V
Drug Dev Ind Pharm; 2013 Jul; 39(7):1091-7. PubMed ID: 22900982
[TBL] [Abstract][Full Text] [Related]
10. Sustained release of PTX-incorporated nanoparticles synergized by burst release of DOX⋅HCl from thermosensitive modified PEG/PCL hydrogel to improve anti-tumor efficiency.
Xu S; Wang W; Li X; Liu J; Dong A; Deng L
Eur J Pharm Sci; 2014 Oct; 62():267-73. PubMed ID: 24931190
[TBL] [Abstract][Full Text] [Related]
11. Development of long-acting bioadhesive vaginal gels of oxybutynin: formulation, in vitro and in vivo evaluations.
Tuğcu-Demiröz F; Acartürk F; Erdoğan D
Int J Pharm; 2013 Nov; 457(1):25-39. PubMed ID: 24036011
[TBL] [Abstract][Full Text] [Related]
12. A (polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer)-dispersed sustained-release tablet for imperialine to simultaneously prolong the drug release and improve the oral bioavailability.
Lin Q; Fu Y; Li J; Qu M; Deng L; Gong T; Zhang Z
Eur J Pharm Sci; 2015 Nov; 79():44-52. PubMed ID: 26349052
[TBL] [Abstract][Full Text] [Related]
13. Enhanced oral bioavailability of novel mucoadhesive pellets containing valsartan prepared by a dry powder-coating technique.
Cao QR; Liu Y; Xu WJ; Lee BJ; Yang M; Cui JH
Int J Pharm; 2012 Sep; 434(1-2):325-33. PubMed ID: 22688251
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of locust bean gum and chitosan combination as a carrier for buccal drug delivery.
Vijayaraghavan C; Vasanthakumar S; Ramakrishnan A
Pharmazie; 2008 May; 63(5):342-7. PubMed ID: 18557416
[TBL] [Abstract][Full Text] [Related]
15. Oral sustained-release suspension based on a lauryl sulfate salt/complex.
Kasashima Y; Uchida S; Yoshihara K; Yasuji T; Sako K; Namiki N
Int J Pharm; 2016 Dec; 515(1-2):677-683. PubMed ID: 27765725
[TBL] [Abstract][Full Text] [Related]
16. Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride.
Feng XM; Ren Q; Zhang WZ; Shen HF; Rong ZX; Fang C; Chen HZ
J Pharm Pharmacol; 2008 Jul; 60(7):817-22. PubMed ID: 18549667
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo correlation of disintegration and bitter taste masking using orally disintegrating tablet containing ion exchange resin-drug complex.
Kim JI; Cho SM; Cui JH; Cao QR; Oh E; Lee BJ
Int J Pharm; 2013 Oct; 455(1-2):31-9. PubMed ID: 23933050
[TBL] [Abstract][Full Text] [Related]
18. Improved sensory properties of a nanostructured ritonavir suspension with a pediatric administration perspective.
Prebianca G; Marques MS; Bianchin MD; Contri RV; Külkamp-Guerreiro IC
Pharm Dev Technol; 2020 Dec; 25(10):1188-1191. PubMed ID: 32746682
[TBL] [Abstract][Full Text] [Related]
19. Effect of drug-ion exchange resin complex in betahistine hydrochloride orodispersible film on sustained release, taste masking and hygroscopicity reduction.
Shang R; Liu C; Quan P; Zhao H; Fang L
Int J Pharm; 2018 Jul; 545(1-2):163-169. PubMed ID: 29729403
[TBL] [Abstract][Full Text] [Related]
20. Nanocrystals of medium soluble actives--novel concept for improved dermal delivery and production strategy.
Zhai X; Lademann J; Keck CM; Müller RH
Int J Pharm; 2014 Aug; 470(1-2):141-50. PubMed ID: 24813782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
